Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Canopy Growth Statement Regarding Possible Class Action Related to Mettrum Health Corp. Recall
SMITHS FALLS, ON, March 7, 2017 /CNW/ – Details of a possible class action suit naming Mettrum Health Corp., an entity that was fully acquired by Canopy Growth Corporation (“Canopy Growth” or “the Company”) (TSX: WEED) (OTC: TWMJF) on January 31, 2017 have been publicly reported.
In response to these reports, the Company wishes to state that it conducted thorough due diligence during the process of acquiring Mettrum Health Corp. and was aware of the extent and scope of the recall Mettrum was conducting.
Canopy Growth was, and continues to be satisfied with Health Canada’s independent decision to classify the Mettrum recall as a Type III recall, defined as “a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.”
The Company will defend itself vigorously against all suits relating to Mettrum recalls.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of indoor and greenhouse production capacity. Canopy Growth has established partnerships with leading sector names in Canada and abroad. For more information visit www.canopygrowth.com.
For fact-based information on Canopy Growth Corp, view the company’s sponsored Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.